Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -71.00M
March 31, 2026 -50.08M
December 31, 2025 -68.90M
September 30, 2025 -56.25M
June 30, 2025 -49.06M
March 31, 2025 -39.30M
December 31, 2024 -60.58M
September 30, 2024 -41.84M
June 30, 2024 -38.38M
March 31, 2024 -45.35M
December 31, 2023 76.07M
September 30, 2023 -40.26M
June 30, 2023 -19.41M
March 31, 2023 -30.09M
December 31, 2022
Date Value
September 30, 2022
June 30, 2022 51.05M
March 31, 2022 121.10M
December 31, 2021 -30.48M
September 30, 2021 -22.56M
June 30, 2021 -26.11M
March 31, 2021 -20.75M
December 31, 2020 -34.11M
September 30, 2020 -58.97M
June 30, 2020 15.88M
March 31, 2020 -33.79M
December 31, 2019 27.38M
September 30, 2019 52.41M
June 30, 2019 -6.275M
March 31, 2019 -0.6597M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
BioNTech SE -52.17M
MediGene AG --
InflaRx NV -2.979M
Twist Bioscience Corp. -8.648M
Prime Medicine, Inc. -41.09M